About FlareOn Biotech
FlareOn Biotech offers a new rapid tumor margin assessment tool for head and neck cancer directly in the operating room. Our patented sensor lights up in response to active biomarkers within removed tumor tissue, helping surgeons make critical decisions at the point of need to ensure complete cancer removal. This reduces time and costs while improving patient care.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Founding: 2024
- Focus : Manufacturer
- Industry : Diagnostics
Advertisement
